Charles Elliott Sigal - 08 Jun 2021 Form 4 Insider Report for Surface Oncology, Inc. (SURF)

Role
Director
Signature
/s/ Jessica Fees, as Attorney-in-Fact
Issuer symbol
SURF
Transactions as of
08 Jun 2021
Transactions value $
$0
Form type
4
Filing time
10 Jun 2021, 16:30:28 UTC
Previous filing
25 May 2021
Next filing
02 Jul 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +17.7K $0.00 17.7K 08 Jun 2021 Common Stock 17.7K $7.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options shall vest in full upon the earlier to occur of the first anniversary of the date of grant or the date of the next Annual Meeting; provided, however, that all vesting shall cease if the director resigns from the Board of Directors or otherwise ceases to serve as a director, unless the Board of Directors determines that the circumstances warrant continuation of vesting.